Journals | Policy | Permission

Journal of Endocrinology & Metabolism

Editorial

Volume 8, Number 4, August 2018, pages 55-56

Diabetes Evaluation Sheet

Our institute, National Center for Global Health and Medicine Kohnodai Hospital treats many severe diabetic patients and studies various aspects of diabetes. To improve the quality of diagnosis and treatment for diabetes and also to accelerate studies on diabetes worldwide, here we will show our “NCGM Kohnodai Diabetes Evaluation Sheet” (Fig. 1).

Click for large image

Figure 1. NCGM Kohnodai Diabetes Evaluation Sheet

This sheet includes the information about age, sex, body height and weight, body mass index, classification (etiology) of diabetes, duration of diabetes, treatments for diabetes, glycemic control, macrovascular and microvascular complications, insulin secretary capacity and insulin resistance, and coronary risk factors. In this sheet, we evaluate nephropathy according to the classification of diabetic nephropathy (The Japan Diabetes Society) made based on the study by Wada T et al [1], and we also evaluate estimated glomerular filtration rate (eGFR) category in chronic kidney disease (CKD) by using KDIGO 2012 CKD Guideline [2]. Furthermore, we evaluate insulin resistance by using homeostasis model assessment of insulin resistance (HOMA-IR), and also evaluate intrinsic insulin secretary capacity by using homeostasis model assessment of β-cell function (HOMA-β) and C-peptide immunoreactivity index (CPI index) [3, 4].

Therefore, NCGM Kohnodai Diabetes Evaluation Sheet helps us to make a valid diagnosis and an appropriate treatment for severe diabetic patients. This sheet is also very useful for educating young doctors about diabetes. We produce two to three diabetes specialists every year. Furthermore, this sheet may contribute to our research activities. We have reported 83 English original articles (total impact factor, 185.2) since 2013, by using this sheet.

We strongly hope that the diagnosis and treatment for diabetes, and research of diabetes worldwide will develop by using this sheet.

Conflict of Interest

The authors declare that they have no conflict of interest concerning this article.

1. Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18(4):613-620.
   doi pubmed
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013:3;1-150.
3. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
   doi pubmed
4. Iwata M, Matsushita Y, Fukuda K, Wakura T, Okabe K, Koshimizu Y, Fukushima Y, et al. Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients. J Diabetes Investig. 2014;5(5):570-580.
   doi pubmed

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Endocrinology and Metabolism is published by Elmer Press Inc.